Nicolette A.
- Country
- The Netherlands
- Department
- Arends
Research Overview
- Long-term Evaluation of DBV712 in Pediatric Peanut Allergy: An Open-label Extension Study on Clinical Benefit and Safety
- A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of Epicutaneous Immunotherapy with DBV712 250 μg in 4-7-year-old Children with Peanut Allergy (VITESSE)
- A Phase 3, Double-Blind, Placebo-Controlled, Randomized Study to Assess the Safety of Epicutaneous Immunotherapy with DBV712 250 µg in 1-through 3-year-old Children with Peanut Allergy
Data & Insights
Has run more than one trial at 5 of 21 partner sites.
Specializations
Allergy and Immunotherapy
The investigator specializes in the study of peanut allergy treatments, with particular focus on epicutaneous immunotherapy approaches for pediatric patients.
- Pediatric Allergy Management
- Long-term Desensitization Protocols
- Food Allergy Immunotherapy
Their research encompasses innovative therapeutic strategies for children aged 4-7 years with peanut allergies.
Pediatric Medicine
The investigator focuses on developing treatment protocols specifically designed for young children with food allergies, emphasizing safety and clinical effectiveness.
- Child-Specific Treatment Approaches
- Safety Assessment in Pediatric Patients
- Long-term Clinical Monitoring
Their work integrates extended observation periods to ensure optimal therapeutic outcomes in pediatric populations.
Clinical Immunology
The investigator's expertise centers on immune system modulation through specialized immunotherapy techniques for allergic conditions.
- Novel Immunotherapy Applications
- Immune Response Monitoring
- Allergy Desensitization Protocols
Their research explores innovative approaches to achieving sustained immunological responses in allergy treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.